Segmented Information |
9 Months Ended | ||
|---|---|---|---|
Jul. 31, 2026 | |||
| Segmented Information [Abstract] | |||
| Segmented Information |
As of July 31, 2026, the Company has one operating segment, being the research and development of novel psychedelic medicine, which takes place primarily in Israel. |